We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

December 17, 2021

A Year in Review: Top 10 Things We Saw and Did in 2021

Commentary
Sophie Madden and Meaghan Schedel
&

This was a booming year of growth in the world of digital health, with first of their kind investments, acquisitions and product launches. We’ve captured the top 10 things we saw and did in our 2021 year in review. 


What we saw: 


1. COVID-19 impacted digital health adoption and ROI in a positive way 

At the start of 2021 we predicted Health @ Home would be the future, shifting patient care away from the traditional hospital setting. Our community insights echoed this with 67% of those polled investing and partnering more, 22% investing and partnering more conservatively, and only 11% believing there were bigger concerns than investing in digital health.


2. Pharma- DTx partnerships tended to be ‘’combination’’ DTx 

While in recent years we’ve seen pharma start to embrace standalone DTx, this past year most new DTx partnerships (87.5%) focused on digital companions. In terms of therapeutic areas, metabolic (diabetes) was the most popular. 


3. Big Tech saw the challenges of being in healthcare

The same week that Google dismantled its Health Division, Apple announced it was scaling back their app project, Health Habit. The retreat shows the challenges Big Tech faces in entering the complex and fragmented healthcare system and the need to possibly change their approach. 


4. Slow uptake of DiGA leads to question of the model’s sustainability 

With the first 10 DiGAs introduced in 2020, we saw the library add an additional 15 solutions in 2021. While some countries, like France, are adopting DiGA-like models, others say approval (25 apps) and prescription numbers (50,000) in Germany are still too low to show success and sustainability at this stage. 


5. 2021 was the year for mental health apps, mergers and acquisitions 

There’s been a rise in attention to mental health as a result of COVID-19, with digital health being well positioned to support growing needs. We saw a flurry of activity in this space, including Amwell acquiring Silvercloud Health, Headspace and ginger.io merging to form Headspace Health, and Woebot receiving FDA breakthrough designation for their postpartum depression prescription digital therapeutic.



What we did at HealthXL:


1. We hosted over 178 virtual meetings, 2 in person Global Gatherings and 2 Cross-Industry Working Groups

HealthXL’s virtual meetings offered a chance for community members to connect at a time when in person meetings were at a standstill. We discussed the future of digital health, solutions to key challenges in the space, and the evolving landscape. Our Global Gatherings in Boston and Dublin this fall brought together innovators and global leaders from all areas of digital health. HealthXL also hosted a pre-competitive cross-industry working group that convened to create an open-source guidance to facilitate digital health vendor assessment for clinical trials and a working group on the future of skin health.


2. We got deeper in DTx

This past year we published two reports diving into the areas of Prescription Digital Therapeutics and DTx routes to market. Check out our PDT report and Part I of the DTx routes to market report now and keep an eye out for Part II coming in January!  


3. We launched an App and 5 new HealthXL Communities 

The HealthXL app brings news, networking and meetings to your fingertips. The HealthXL app is now available for Android and iOS. Our communities allow experts to get the latest news and curated insights from the HealthXL team while connecting with their peers on key areas of interest. Our DTx community has over 130 active members with our Telemedicine & Virtual Care, Clinical Trials Innovation, Digital Mental Health & Neurology, and The Future of Skin Health communities growing daily.  


4. We grew by 32% this past year
We were delighted to welcome new HealthXL members across all of our teams this year. We plan to continue to grow in 2022 and have already published several job postings. Interested in joining our team? Check here

5. We added new products to our Advisory offerings
We’ve been providing expert insights and perspectives to our clients for over eight years with a focus on bringing together the people and insights to solve some of the industry’s biggest challenges, and helping them evolve their digital health programs. This past year we added Ideation Workshops and Opportunity and Trends Assessments, among others to our portfolio of offerings. Some of our most popular offerings are Market Landscape Analysis and Bespoke Digital Health Workgroups. Interested in learning more? Reach out here


And that’s a wrap on 2021! This will be our last blog of the year as we begin to wind down for the holidays. Our offices will be closed from December 27th - January 3rd but we look forward to reconnecting with you all in the new year! 


We’ll be starting the year off with a blog on our top 5 predictions for 2022 and our first in-person event of the year in Basel on February 24th. We can’t wait to see you there! 


Until then, from all of us at HealthXL, happy holidays, and here's to a brighter 2022!



We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.


We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: DTx Reimbursement in the US - PBMs as Coverage Scale Catalysts

10th August @ 10:45AM EDT

Are you a DTx or Pharma company seeking wide-spread reimbursement of a DTx product in the US? Join this Masterclass led by Mike Pace to learn more about this topic and share your experiences with others working in this space.

Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co
Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: Value, Cost and Pricing in Regulated Digital Health Solutions

11th August @ 10:45AM EDT

Digital Health solutions are top of mind for biopharma companies in 2022, and Software as Medical Device (SaMD) is a crucial cornerstone for top-tier companies. Join this Masterclass led by BrightInsight to dive deeper into this topic and discuss this further with your peers working in this space.

Featuring
David Matthews, PhD
David Matthews, PhD
CCO, BrightInsight
Featuring
David Matthews, PhD
David Matthews, PhD
CCO, BrightInsight
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sustainable Business Models for DTx

16th August @ 10:45AM EDT

It is one of the key questions that every digital therapeutic (DTx) company must answer - what business model will set them up for success in the long run? Join this meeting to discuss this further and share your experiences with your peers working in this space.

Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Payers Partnerships for DTx

17th August @ 10:45AM EDT

Digital Therapeutics (DTx) vendors face many challenges on their journey to commercialization, such as generating clinical data, health economics evidence and achieving regulatory status. Join this meeting to discuss this topic further and share your experiences with others working in this space.

Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Kevin Darcy
Kevin Darcy
Director, Link Strategy at Veeva Systems
Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Kevin Darcy
Kevin Darcy
Director, Link Strategy at Veeva Systems

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: DTx Reimbursement in the US - PBMs as Coverage Scale Catalysts

10th August @ 10:45AM EDT

Are you a DTx or Pharma company seeking wide-spread reimbursement of a DTx product in the US? Join this Masterclass led by Mike Pace to learn more about this topic and share your experiences with others working in this space.

Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co
Featuring
Michael Pace
Michael Pace
CEO & Founder at PalmHealth.co
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: Value, Cost and Pricing in Regulated Digital Health Solutions

11th August @ 10:45AM EDT

Digital Health solutions are top of mind for biopharma companies in 2022, and Software as Medical Device (SaMD) is a crucial cornerstone for top-tier companies. Join this Masterclass led by BrightInsight to dive deeper into this topic and discuss this further with your peers working in this space.

Featuring
David Matthews, PhD
David Matthews, PhD
CCO, BrightInsight
Featuring
David Matthews, PhD
David Matthews, PhD
CCO, BrightInsight

Executive 1-2-1 with the HealthXL Digital Health Community

15th August @11AM EDT

Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!

Featuring
Aahuti Rai
Aahuti Rai
Strategic Advisor, Healthcare Innovation at Four Points Consulting Ltd
Chris Wasden
Chris Wasden
Head of Pharma Speciality Solutions & Corporate Strategy, Twill
Featuring
Aahuti Rai
Aahuti Rai
Strategic Advisor, Healthcare Innovation at Four Points Consulting Ltd
Chris Wasden
Chris Wasden
Head of Pharma Speciality Solutions & Corporate Strategy, Twill
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Sustainable Business Models for DTx

16th August @ 10:45AM EDT

It is one of the key questions that every digital therapeutic (DTx) company must answer - what business model will set them up for success in the long run? Join this meeting to discuss this further and share your experiences with your peers working in this space.

Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Featuring
Elena Mustatea
Elena Mustatea
CEO, Bold Health
Rick Bartels
Rick Bartels
Managing Partner , DTxCC

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.